KeyBioscience AG
Records under this name other than the patents KeyBioscience AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,833,494 | Methods of treating medical conditions using peptides Lapsed on the fee record Ended Dec 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 5, 2025 | From the USPTO record |
| US 8,497,347 | Methods of treating medical conditions using peptides Lapsed on the fee record Ended Jul 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 30, 2025 | From the USPTO record |
| US 8,378,067 | Treatment for obesity Lapsed on the fee record Ended Feb 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 19, 2025 | From the USPTO record |
| US 8,076,291 | Treatment for obesity Lapsed on the fee record Ended Dec 13, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2023 | From the USPTO record |
| US 10,350,272 | Calcitonin analogues for treating diseases and disorders Lapsed on the fee record Ended Jul 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2023 | From the USPTO record |
| US 9,006,172 | Peptide analogs for treating diseases and disorders Lapsed on the fee record Ended Apr 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2023 | From the USPTO record |
| US 10,239,929 | Peptide analogs for treating diseases and disorders Lapsed on the fee record Ended Mar 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 26, 2023 | From the USPTO record |
| US 10,232,021 | Calcitonin mimetics for treating diseases and disorders Lapsed on the fee record Ended Mar 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | From the USPTO record |
| US 9,862,754 | Peptide analogs for treating diseases and disorders Lapsed on the fee record Ended Jan 9, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 9, 2022 | From the USPTO record |
| US 9,533,022 | Peptide analogs for treating diseases and disorders Lapsed on the fee record Ended Jan 3, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2021 | From the USPTO record |